Bristol Myers’ Celgene gamble, Apple’s IPR attack on Qualcomm, 2018’s US patent litigation stats, key CRISPR facts, plus much more – Lexology

Bristol Myers’ Celgene gamble, Apple’s IPR attack on Qualcomm, 2018’s US patent litigation stats, key CRISPR facts, plus much more  Lexology

Patent office officials in Beijing reveal the country’s top patent recipients, amount of cross-border royalty flows and ambiguous data on foreign…